Licorice - OmicsDI

Show results for

Unknown (366)
Genomics (58)
Proteomics (8)
Transcriptomics (7)
Metabolomics (5)

Organisms

Homo sapiens (5)
Rattus norvegicus (2)
Glycyrrhiza uralensis (2)
Mus musculus (2)
Alphavirus (2)
Anemia (2)
Archaea (2)
Bacteria (2)
Betaherpesvirinae (2)
Borrelia (2)
Clostridium perfringens (2)
Cytomegalovirus (2)
Dengue virus (2)
Eukaryota (2)
Hepatitis B virus (2)
Human alphaherpesvirus 1 (2)
Human betaherpesvirus 5 (2)
Human immunodeficiency virus (2)
Influenza A virus (2)
Influenza C virus (2)
Japanese encephalitis virus group (2)
Kamptonema sp. (2)
Listeria monocytogenes (2)
Mammarenavirus (2)
Miscanthus x giganteus (2)
Mycobacterium tuberculosis (2)
Orthoflavivirus (2)
Pseudomonas aeruginosa (2)
Clostridioides difficile (1)
Danio rerio (1)

Organisms

Glycyrrhiza uralensis (9)
Homo sapiens (2)
Mixta hanseatica (1)
Glycyrrhiza glabra (1)
Fusarium solani (1)
rabbit gut metagenome (1)
Clostridioides difficile (1)
Glycyrrhiza inflata (1)
fermentation metagenome (1)
Danio rerio (1)
mouse gut metagenome (1)

Repository

ENA (57)
iProX (5)
geo (4)
biostudies-arrayexpress (3)
MetaboLights (3)
pride (2)
EGA (1)
GNPS (1)
MassIVE (1)
MetabolomicsWorkbench (1)

Tissue

Feces (1)
IMR-32 cell (1)
Liver (1)

Disease

Irritable bowel syndrome (1)
Parkinson's disease (1)

Technology Type

Mass Spectrometry (3)
Mass spectrometry assay (2)
Shotgun proteomics (2)
Mass spectrometry (1)
ESI (1)

Instrument Platform

QTRAP 6500 (2)
Illumina HiSeq 2500 (1)
Gas Chromatography MS - Positive (GC-MS (Pos)) (1)
Liquid Chromatography MS - alternating - reverse-phase (1)
Liquid Chromatography MS - positive - reverse phase (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2026 (4)
2021 (3)
2020 (3)
2019 (2)
2022 (2)
2016 (1)
2014 (1)
2023 (1)

CHEBI ID

CHEBI:59769 (1)
CHEBI:145712 (1)
CHEBI:145743 (1)
CHEBI:145741 (1)
CHEBI:145719 (1)
CHEBI:145718 (1)
CHEBI:145717 (1)
CHEBI:45525 (1)
CHEBI:145711 (1)
CHEBI:145738 (1)
CHEBI:145744 (1)
CHEBI:145716 (1)
CHEBI:62346 (1)
CHEBI:145715 (1)
CHEBI:145713 (1)
CHEBI:145740 (1)
CHEBI:89744 (1)
CHEBI:89676 (1)
CHEBI:77929 (1)
CHEBI:68566 (1)
CHEBI:10575 (1)
CHEBI:37070 (1)
CHEBI:85235 (1)
CHEBI:9661 (1)
CHEBI:89843 (1)
CHEBI:143856 (1)
CHEBI:67252 (1)
CHEBI:69081 (1)
CHEBI:31457 (1)
CHEBI:30813 (1)

Metabolite Name

Glabridin (1)
Dg(I-15:0/0:0/5-Iso Pgf2Vi) (1)
Lysopc(P-18:0/0:0) (1)
Dg(20:4(8Z,11Z,14Z,17Z)/22:1(13Z)/0:0) (1)
Cyclic Rgd (1)
Dl-Asparagine (1)
N6-Cis-P-Coumaroylserotonin (1)
Beta-Citryl-L-Glutamic Acid (1)
Equol 4'-Sulfate (1)
Isovitexin 7-(6'''-Sinapoylglucoside) 4'-Glucoside (1)
Udp-A-D-Galacturonic Acid (1)
Dl-Glycerol 1-Phosphate (1)
2-Hydroxypropyl Glucosinolate (1)
D-4-Hydroxy-2-Oxoglutarate (1)
Cis-Accp (1)
Hydroxy Dabrafenib (1)
Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-Nh2 (1)
Uridine Diphosphate (Udp) (1)
8-Methylsulfinyloctyl Glucosinolate (1)
Cephamycin A (1)
Cyanidin 3-(Malonylsophoroside) 5-Glucoside (1)
N-(1,3-Benzodioxol-5-Ylmethyl)-2,6-Dichlorobenzamide (1)
Evodenoson (1)
Myricetin 3-Neohesperidoside (1)
S-(1,2-Dichlorovinyl)Glutathione (1)
Cholecystokinin C-Terminal Heptapeptide (1)
Lacto-N-Fucopentaose Iii (1)
Dodeca-4,6,8-Trienedioyl-Coa (1)
17-Phenyl Trinor Pgf2Alpha (1)
3-Methyl-9-(2-Methylpropyl)Purine-2,6-Dione (1)

First Public Date

2026 (16)
2019 (10)
2025 (6)
2024 (6)
2023 (6)
2020 (5)
2022 (4)
2021 (3)
2014 (1)

Classification

bacteria (2)
fungi (1)

Study type

RNA-seq of coding RNA (2)
Transcription profiling by array (1)

Release Date

2022 (66)
2023 (54)
2024 (42)
2021 (41)
2025 (40)
2020 (32)
2019 (23)
2018 (15)
2015 (13)
2016 (10)
2017 (9)
2026 (8)
2014 (5)
2013 (3)
2009 (3)
2008 (2)
2011 (1)
2010 (1)
2006 (1)

Lab affiliation

Center for Systems Biology and Molecular Medicine, Yenepoya University, Mangalore 575018 (1)
College of Pharmacy, Gansu University of Chinese Medicine, Lanzhou, China (1)

Tags

pathogen (3)
pathogen:bacterium (2)
xref:PubMed:37253812 (1)
xref:PubMed:42657783 (1)
xref:PubMed:39605440 (1)
xref:PubMed:23589666 (1)
pathogen:fungus (1)

Previous page
1 / 45
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 45
Next page

Sort by:

Relevance

Page size

Study the effect of licorice-yuanhua combination on the gut mucosal barrier

licorice-yuanhua is one of the incompatible herbal pairs in the "Eighteen incompatible Medicaments" of traditional Chinese Medicine. In this study, Chemical compounds in licorice and yuanhua were used to treat the LS174T cells and iTRAQ labled proteomics study was conducted.

ORGANISM(S): Homo Sapiens

2020-04-09 | PXD018456 |

Licorice Ameliorates Cisplatin-Induced Hepatotoxicity through Anti-apoptosis, Anti-oxidative Stress, Anti-inflammation, and Acceleration of Metabolism

Cisplatin (CP) is one of the most effective antitumor drugs in the clinic, but has serious adverse reactions, and its hepatotoxicity has not been fully investigated. Licorice (GC), a traditional herbal medicine, has been commonly used as a detoxifier for poisons and drugs, and may be an effective dr...

ORGANISM(S): Rattus norvegicus (Rat)

2020-11-27 | PXD021688 | Pride